• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: February 15-19, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

February 15-19, 2010

FDA Official and Title

Date

Location

Other FDA Participants

Non-FDA Participants

Subject

Margaret A. Hamburg, M.D., Commissioner of Food and Drugs2/18/10Naples, FLN/AGordon Johnston, Kathleen Jaeger (Generic Pharmaceuticals Association); Paul Bisaro (Watson Pharmaceuticals); William Marth (Teva); Paul Begala (CNN); John Rother (AARP); Doug Long (IMS); Gail Wilensky (Project HOPE); Stephen DubnerSpeech at Generic Pharmaceuticals Association Annual Meeting
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs2/17/10Washington, DCJeanne Ireland, John TaylorMinority staff of the Senate Finance Committee Briefing on Office of Criminal Investigations
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health2/18/10-
2/19/10
Geneva, SwitzerlandN/APrivate Industry, Government and AcademiaWorld Health Organization's 6th Meeting on Evaluation of Pandemic Influenza Prototype Vaccines in Clinical Trials
Russell Abbott, Deputy Commissioner for Administration2/15/10-
2/19/10
N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs2/15/10-
2/19/10
N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget2/15/10-
2/19/10
N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods2/17/10Washington, DCJeanne Ireland, Kristina HarperRoger McClung (Health and Human Services); Minority staff of the House Committee on Energy and CommerceFood Safety
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research2/17/10Bethesda, MDN/ABarbara Alving, Francis Collins (National Institutes of Health); Barry Coller, Kathleen Denis (Clinical and Translational Science Awards)Promoting Efficient and Effective Collaborations among Academia, Government and Industry
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs2/15/10-
2/19/10
N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research2/15/10-
2/19/10
N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/16/10Silver Spring, MDTim Ulatowski, Lillian Gil, Steven SilvermanLarry Kelly (Therapeutic Good Administration)Medical Devices
Stephen Sundlof, D.V.M., Ph.D., Director, Center for Food Safety and Applied Nutrition2/15/10-
2/19/10
Arlington, VAN/AUSDA's Agriculture Outlook Forum 2010Speech on Strengthening America's Food Safety System
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine2/15/10-
2/19/10
N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research2/19/10-
2/20/10
Jonesboro, ARN/AN/A7th Annual Conference of the MidSouth Computational Biology and Bioinformatics Society
Ralph Tyler, J.D., Chief Counsel2/15/10-
2/19/10
N/AN/AN/ANo Significant Meetings 
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products2/15/10-
2/19/10
N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs2/15/10-
2/19/10
N/AN/AN/ANo Significant Meetings